Computationally Guided Design of Two Novel Soluble Epoxide Hydrolase Inhibitors
Dere, E. C.; Chu, S. S.; Ortega, T.; Huang, P.; Siegel, J. B.
Show abstract
The enzyme soluble epoxide hydrolase (sEH) has been found to play a role in many ailments such as inflammation, pain, renal function, pulmonary function, hypertension, and diabetes. Multiple sEH inhibitors have been developed to reduce the adverse effects of the ailments. Due to high inhibitory concentrations, there is urgent need for developing improved sEH inhibitors. In this study, two novel sEH inhibitors were designed via computational bioisosteric replacement and chemical intuition with the goal of increasing binding affinity, which can potentially decrease inhibitory concentration. The new drug candidates were found to have improved binding properties compared to existing drugs.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 97%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 96%
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 97%
- Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology and Target Identification of Thio-wurtzine, a Potent Inhibitor of the Opioid Receptors and the Voltage-Dependent Calcium Channels 95%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 94%
Similar papers in this journal
- De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia 96%
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 96%
- Structural analysis and ensemble docking revealed the binding modes of selected progesterone receptor modulators 96%
Similar papers in this journal
- Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for SARS-CoV-2 3CL Protease 93%
- Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection 93%
- Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitors 92%
Similar papers in this journal
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 96%
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 95%
- PeruNPDB: The Peruvian Natural Products Database for in silico drug screening 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.